[1]
2017. Pan genotypic response to combination treatment with Sofosbuvir and Daclatasvir in chronic Hepatitis C patients. International Journal of Biomedical Research. 8, 6 (Jun. 2017), 333–338. DOI:https://doi.org/10.7439/ijbr.v8i6.4220.